Saiid Zarrabian leads Kintara Therapeutics, a biotech firm formed in August 2020 through the acquisition of Adgero Biopharmaceuticals by Delmar.
Saiid Zarrabian leads Kintara Therapeutics, a biotech firm formed in August 2020 through the acquisition of Adgero Biopharmaceuticals by Delmar Pharmaceuticals. He has nearly 30 years' experience as a senior executive, advisor, and board member, with the past 25 years focused on turnaround strategies in the life sciences industry.
Full founder directory · Investor directory · Company funding database · Fundraising library